EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Analysis of the clinical characteristics and prognostic factors of multicenter childhood Burkitt leukemia

Wenting Pei, Yanlong Duan, Ling Jin, Xiaomei Yang, Yunpeng Dai, Mincui Zheng, Leping Zhang, Ying Liu, Xiaojun Yuan, Kailan Chen, Lirong Sun, Jian Jiang und 14 weitere

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06672-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, 2025. Verfasst von Wenting Pei und 25 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, 250022, China. Hauptthemen laut MEDLINE: Burkitt Lymphoma. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority, Science and Technology Development Program of Jinan Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Burkitt lymphoma (BL) is a B-cell malignancy with a rapid doubling time, originating in follicular germinal centers. We aimed to explore the characteristics and prognosis of childhood Burkitt leukemia. A total of 124 children with Burkitt leukemia enrolled during the 6-year period of China Net Childhood Lymphoma- mature B-cell lymphoma 2017 regimen (CNCL-B-NHL-2017) were assessed. The median age at onset was 7 years (1-15 years), with a male-to-female ratio of 4.17:1. Of the total, 50.8% children were aged 5-10 years. Children with Burkitt leukemia were more likely to have tumor lysis syndrome, renal insufficiency, lactate dehydrogenase (LDH) > 4 times, multiple organ involvement, and central nervous system infiltration at diagnosis, whereas those with large tumor mass were rare. Eleven children had pure Burkitt leukemia (8.9%), with no significant differences in relapse, progression, white blood cell counts at initial diagnosis, LDH levels, CNS infiltration, and rates of tumor lysis syndrome before treatment compared to those of children with tumor masses. (P > 0.05). The median follow-up time for the entire group was 32.85 months (0.4-70.7), with 3-year overall survival and event-free survival rates of 87.1% and 81.5%, respectively. Thirteen (10%) children progressed or relapsed during treatment, of which nine received chimeric antigen receptor T-cell therapy, with only three fatalities. The analysis identified residual disease at midterm evaluation (P = 0.024) and LDH elevation ≥ 2000 U/L (P = 0.014) as independent prognostic factors affecting survival. The CNCL-B-NHL-2017 protocol demonstrated significant efficacy in treating children with Burkitt leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkitt LymphomaHumansChildMaleFemaleChild, PreschoolAdolescentInfantPrognosisChinaAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesSurvival RateRetrospective Studies

Stichwörter der Autor:innen

Burkitt leukemiaChildrenClinical featuresPrognosis

Autor:innen und Institutionen

  • Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, 250022, China.
  • Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
  • Hunan Children's Hospital, Changsha, 410007, China.
  • Peking University People's Hospital, Beijing, 100044, China.
  • Beijing Gobroad Boren Hospital, Beijing, 100070, China.

Förderung

  • Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority
  • Science and Technology Development Program of Jinan Municipal Health Commission

Zitieren

APA

Pei, W., Duan, Y., Jin, L., Yang, X., Dai, Y., Zheng, M., Zhang, L., Liu, Y., Yuan, X., Chen, K., Sun, L., Jiang, J., Zhai, X., Liu, A., Liu, R., Wang, J., Liu, W., Zhang, B., Liu, Y., …, & Li, F. (2025). Analysis of the clinical characteristics and prognostic factors of multicenter childhood Burkitt leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-025-06672-9

Vancouver

Pei W, Duan Y, Jin L, Yang X, Dai Y, Zheng M, et al. Analysis of the clinical characteristics and prognostic factors of multicenter childhood Burkitt leukemia. Annals of Hematology. 2025. doi:10.1007/s00277-025-06672-9

BibTeX
@article{Pei2025,
  author = {Pei, Wenting and Duan, Yanlong and Jin, Ling and Yang, Xiaomei and Dai, Yunpeng and Zheng, Mincui and Zhang, Leping and Liu, Ying and Yuan, Xiaojun and Chen, Kailan and Sun, Lirong and Jiang, Jian and Zhai, Xiaowen and Liu, Ansheng and Liu, Rong and Wang, Jian and Liu, Wei and Zhang, Baoxi and Liu, Yufeng and Wang, Xige and Jiang, Lian and Yang, Lihua and Zhou, Chunju and Gao, Zifen and Zhang, Yonghong and Li, Fu},
  title = {Analysis of the clinical characteristics and prognostic factors of multicenter childhood Burkitt leukemia},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06672-9}
}
Kostenlos starten →